STABLE ANTI-CLEVER-1 ANTIBODY FORMULATION

The invention relates to stable formulations comprising ananti-CLEVER-1 antibody or antigen binding fragment(s)thereof, a buffer and a stabilizing agent. The present invention further relates to stable formulations of an anti-CLEVER-1 antibody or antigen binding fragments thereof for use in treatmen...

Full description

Saved in:
Bibliographic Details
Main Authors MANDELIN, JAMI, VAINIO, MARITA
Format Patent
LanguageEnglish
French
Published 23.12.2021
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The invention relates to stable formulations comprising ananti-CLEVER-1 antibody or antigen binding fragment(s)thereof, a buffer and a stabilizing agent. The present invention further relates to stable formulations of an anti-CLEVER-1 antibody or antigen binding fragments thereof for use in treatment of various diseases and disorders. L'invention concerne des formulations stables comprenant un anticorps anti-CLEVER-1 ou un ou plusieurs fragments de liaison à l'antigène associés, une solution tampon et un agent stabilisant. La présente invention concerne en outre des formulations stables d'un anticorps anti-CLEVER-1 ou de fragments de liaison à l'antigène associés destinées à être utilisées dans le traitement de divers troubles et maladies.
Bibliography:Application Number: CA20213178066